- Home
- HBB vs ACHV Comparison
HBB vs ACHV Comparison
Compare HBB & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBB
- ACHV
- Stock Information
- Founded
- HBB 1904
- ACHV N/A
- Country
- HBB United States
- ACHV United States
- Employees
- HBB N/A
- ACHV N/A
- Industry
- HBB Home Furnishings
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- HBB Consumer Discretionary
- ACHV Health Care
- Exchange
- HBB Nasdaq
- ACHV Nasdaq
- Market Cap
- HBB 186.5M
- ACHV 167.6M
- IPO Year
- HBB 2017
- ACHV N/A
- Fundamental
- Price
- HBB $14.24
- ACHV $4.36
- Analyst Decision
- HBB
- ACHV Strong Buy
- Analyst Count
- HBB 0
- ACHV 1
- Target Price
- HBB N/A
- ACHV $12.00
- AVG Volume (30 Days)
- HBB 18.7K
- ACHV 858.6K
- Earning Date
- HBB 11-05-2025
- ACHV 11-06-2025
- Dividend Yield
- HBB 3.42%
- ACHV N/A
- EPS Growth
- HBB 24.53
- ACHV N/A
- EPS
- HBB 2.34
- ACHV N/A
- Revenue
- HBB $607,430,000.00
- ACHV N/A
- Revenue This Year
- HBB N/A
- ACHV N/A
- Revenue Next Year
- HBB N/A
- ACHV N/A
- P/E Ratio
- HBB $5.91
- ACHV N/A
- Revenue Growth
- HBB N/A
- ACHV N/A
- 52 Week Low
- HBB $12.72
- ACHV $1.84
- 52 Week High
- HBB $21.20
- ACHV $5.78
- Technical
- Relative Strength Index (RSI)
- HBB 51.18
- ACHV 48.25
- Support Level
- HBB $13.75
- ACHV $4.27
- Resistance Level
- HBB $14.49
- ACHV $4.90
- Average True Range (ATR)
- HBB 0.48
- ACHV 0.31
- MACD
- HBB 0.01
- ACHV -0.12
- Stochastic Oscillator
- HBB 60.27
- ACHV 6.25
About HBB Hamilton Beach Brands Holding Company
Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products and Health.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.